Press releasePRNewswire
scPharmaceuticals
SCPH · NASDAQ
Price unavailable right now.
No price history for this range.
Latest news
- Press releaseGlobe Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZIMV, ARIS, SCPH on Behalf of Shareholders
- Press releaseBusiness Wire
SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHCO, VRNT, SCPH on Behalf of Shareholders
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWE, BKH, MURA, SCPH on Behalf of Shareholders
- Press releaseGlobe Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMXI, HBI, VTLE, SCPH on Behalf of Shareholders
- Press releaseBusiness Wire
SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH
- Press releaseGlobe Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTLE and SCPH on Behalf of Shareholders
- NewsVandana Singh
MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCPH, VTLE, CRGY on Behalf of Shareholders
- Press releaseBusiness Wire
SCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of scPharmaceuticals Inc. Is Fair to Shareholders
- Press releaseBusiness Wire
Shareholder Alert: The Ademi Firm Investigates Whether scPharmaceuticals Inc. Is Obtaining a Fair Price for Its Public Shareholders
- Press releaseGlobe Newswire
scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
- News
Earnings Scheduled For August 7, 2025
- Press releaseGlobe Newswire
scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025
- News
Earnings Scheduled For May 14, 2025
- News
Insights Ahead: scPharmaceuticals's Quarterly Earnings
- Press releaseGlobe Newswire
scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025
- Press releaseGlobe Newswire
scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences
- News
Analyst Expectations For scPharmaceuticals's Future
- News
Earnings Scheduled For March 19, 2025
- Press releaseGlobe Newswire
scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025
- Press releaseGlobe Newswire
scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences
- Press releaseGlobe Newswire
scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
- Press releaseGlobe Newswire
scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update
- News
Earnings Scheduled For November 13, 2024
- News
scPharmaceuticals's Earnings Outlook
- Press releaseGlobe Newswire
scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Press releaseGlobe Newswire
scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
scPharmaceuticals to Announce Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.